Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The added value of integrative medicine

Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos

The added value of integrative medicine ( Dr Marta Capelan, Dr Beth DuPree and Rosa Olmos )

Urine test could reduce post-op scans for kidney cancer by half

Dr Saeed Dabestani - Lund university, Lund, Sweden

Urine test could reduce post-op scans for kidney cancer by half ( Dr Saeed Dabestani - Lund university, Lund, Sweden )

Micro-ultrasound is as effective as MRI in detecting prostate cancer

Dr Laurence Klotz - Sunnybrook Health Sciences Centre, Toronto, Canada

Micro-ultrasound is as effective as MRI in detecting prostate cancer ( Dr Laurence Klotz - Sunnybrook Health Sciences Centre, Toronto, Canada )

Bone-protective agents given with enzalutamide with or without radium-223 show...

Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada

Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC ( Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada )

Darolutamide plus ADT provides deep and durable PSA responses in metastatic...

Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada

Darolutamide plus ADT provides deep and durable PSA responses in metastatic hormone-sensitive prostate cancer ( Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada )

Transperineal biopsy improves prostate cancer detection

Prof Richard Bryant - Churchill Hospital in Oxford, Oxford, UK

Transperineal biopsy improves prostate cancer detection ( Prof Richard Bryant - Churchill Hospital in Oxford, Oxford, UK )

Adjuvant docetaxel shows no significant advantage compared to surveillance in...

Dr Pirkko-Liisa Kellokumpu-Lehtinen - Tampere University Hospital, Tampere...

Adjuvant docetaxel shows no significant advantage compared to surveillance in high-risk prostate cancer after 10 years ( Dr Pirkko-Liisa Kellokumpu-Lehtinen - Tampere University Hospital, Tampere, Finland )

TAR-200 plus cetrelimab show encouraging outcomes for MIBC patients ineligible...

Dr Sarah Psutka - University of Washington, Seattle, USA

TAR-200 plus cetrelimab show encouraging outcomes for MIBC patients ineligible for standard cisplatin-based chemotherapy ( Dr Sarah Psutka - University of Washington, Seattle, USA )

EAU 2025: Updates in NMIBC

Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Alexandra Masson-Lecomte and...

EAU 2025: Updates in NMIBC ( Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Alexandra Masson-Lecomte and Dr Giuseppe Simone )

Challenges of managing patients with NMIBC: from risk stratification to...

Dr Benjamin Pradère, Dr Bernadett Szabados, Prof Shahrokh Shariat

Challenges of managing patients with NMIBC: from risk stratification to treatment and beyond ( Dr Benjamin Pradère, Dr Bernadett Szabados, Prof Shahrokh Shariat )

Enzalutamide with 5-ARI is safe for older patients with castration-sensitive...

Dr Sindhuja Kadambi - University of Rochester Medical Center, Rochester, USA

Enzalutamide with 5-ARI is safe for older patients with castration-sensitive systemic prostate cancer ( Dr Sindhuja Kadambi - University of Rochester Medical Center, Rochester, USA )

Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant...

Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston...

Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients ( Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA )

More from ecancer